verapamil has been researched along with Hypothyroidism in 8 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Hypothyroidism: A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aim of this study was to investigate antiarrhythmic and toxic effects of verapamil in mice and rats with thyrotoxicosis and hypothyroidism." | 7.74 | [Characteristics of pharmacological and toxic effects of verapamil during cardiac arrhythmia in thyrotoxic and hypothyroid rats]. ( Afanas'eva, EIu; Arzamastsev, EV; Sokhanenkov, MIu; Sokhanenkova, AE, 2008) |
| "In some patients with severe hypothyroidism, thyroxine replacement therapy precipitates or aggravates angina pectoris, whereas in other patients angina pectoris is ameliorated or even cured." | 7.68 | Cardiac left ventricular function before and during early thyroxine treatment in severe hypothyroidism. ( Bernstein, R; Haug, E; Hertzenberg, L; Kjørstad, KE; Midtbø, K; Müller, C; Nakken, KF, 1991) |
| "Aim of this study was to investigate antiarrhythmic and toxic effects of verapamil in mice and rats with thyrotoxicosis and hypothyroidism." | 3.74 | [Characteristics of pharmacological and toxic effects of verapamil during cardiac arrhythmia in thyrotoxic and hypothyroid rats]. ( Afanas'eva, EIu; Arzamastsev, EV; Sokhanenkov, MIu; Sokhanenkova, AE, 2008) |
| "In some patients with severe hypothyroidism, thyroxine replacement therapy precipitates or aggravates angina pectoris, whereas in other patients angina pectoris is ameliorated or even cured." | 3.68 | Cardiac left ventricular function before and during early thyroxine treatment in severe hypothyroidism. ( Bernstein, R; Haug, E; Hertzenberg, L; Kjørstad, KE; Midtbø, K; Müller, C; Nakken, KF, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sokhanenkova, AE | 1 |
| Sokhanenkov, MIu | 1 |
| Afanas'eva, EIu | 1 |
| Arzamastsev, EV | 1 |
| Andersson, DE | 1 |
| Röjmark, S | 1 |
| Veksler, VI | 1 |
| Levitskaya, EL | 1 |
| Khatkevich, AN | 1 |
| Orekhova, IV | 1 |
| Khuchua, ZA | 1 |
| Kapelko, VI | 1 |
| Doughty, JC | 1 |
| Donald, AK | 1 |
| Keogh, G | 1 |
| Cooke, TG | 1 |
| Seppet, EK | 1 |
| Kolar, F | 1 |
| Dixon, IM | 1 |
| Hata, T | 1 |
| Dhalla, NS | 1 |
| Bernstein, R | 1 |
| Müller, C | 1 |
| Midtbø, K | 1 |
| Haug, E | 1 |
| Nakken, KF | 1 |
| Hertzenberg, L | 1 |
| Kjørstad, KE | 1 |
| Hagino, Y | 1 |
| Nomura, H | 1 |
| Nomura, T | 1 |
| Maekawa, H | 1 |
| Izuhara, K | 1 |
| Tachibana, M | 1 |
| De Marinis, L | 1 |
| Mancini, A | 1 |
| Minnielli, S | 1 |
| D'Amico, C | 1 |
| Di Pietro, ML | 1 |
| Albini, C | 1 |
| Passeri, M | 1 |
| Liberale, I | 1 |
| Menini, E | 1 |
| Barbarino, A | 1 |
8 other studies available for verapamil and Hypothyroidism
| Article | Year |
|---|---|
[Characteristics of pharmacological and toxic effects of verapamil during cardiac arrhythmia in thyrotoxic and hypothyroid rats].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dose-Response Relatio | 2008 |
Effect of verapamil on blood glucose and serum insulin in patients with hyper- and hypothyroidism.
Topics: Adult; Aged; Blood Glucose; Female; Humans; Hyperthyroidism; Hypothyroidism; Insulin; Male; Middle A | 1980 |
Myocardial adaptation to long-term action of substances associated with decreased intensity of cardiac function.
Topics: Adaptation, Physiological; Adenosine Triphosphatases; Animals; Body Weight; Calcium; Heart; Hypothyr | 1994 |
Stercoral perforation with verapamil.
Topics: Aged; Chronic Disease; Constipation; Female; Humans; Hypothyroidism; Intestinal Perforation; Sigmoid | 1994 |
Regulation of cardiac sarcolemmal Ca2+ channels and Ca2+ transporters by thyroid hormone.
Topics: Animals; Calcium Channels; Calcium-Binding Proteins; Heart; Hyperthyroidism; Hypothyroidism; In Vitr | 1993 |
Cardiac left ventricular function before and during early thyroxine treatment in severe hypothyroidism.
Topics: Adult; Aged; Exercise Test; Female; Gated Blood-Pool Imaging; Humans; Hypothyroidism; Male; Middle A | 1991 |
The role of calcium ion in methoxamine-induced amylase release from parotid glands of euthyroid and hypothyroid rats.
Topics: Adrenergic alpha-Agonists; Amylases; Animals; Calcium; Calmodulin; Hypothyroidism; Male; Methoxamine | 1985 |
Calcium antagonists and hormone release. V. Effects of a calcium-antagonist (verapamil) on pituitary hormone release in hypersecretory states.
Topics: Acromegaly; Adolescent; Adult; Cushing Syndrome; Female; Humans; Hypogonadism; Hypothyroidism; Male; | 1987 |